Emerging clinical issues in refugees

Current Opinion in Infectious Diseases

Volumn 22, Issue 5, 2009, Pages 436-442

  Stauffer, William M ^a,b   Weinberg, Michelle ^b  

^a Infectious Diseases Section   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Infection; Intestinal parasite; Malaria; Mobile population; Refugees

Indexed keywords

CLINICAL FEATURE; EOSINOPHILIA; EPIDEMIC; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; INTESTINE PARASITE; MALARIA; MEDICAL SPECIALIST; MIGRATION; NONHUMAN; PUBLIC HEALTH; REFUGEE; REVIEW; SCREENING; TUBERCULOSIS; UNITED STATES;

COMMUNICABLE DISEASES; HUMANS; REFUGEES; WORLD HEALTH;

EID: 70249125856     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832f14a4     Document Type: Review

References (31)

1. Marx A, Pewsner D, Egger M, Nüesch R, et al. Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas. Ann Intern Med 2005; 142:836-847.
2. Murray CK, Gasser RA Jr, Magill AJ, Miller RS. Update on rapid diagnostic U.S. Department of State. Proposed refugee admission guidelines for fiscal year 2006 report to Congress. US Department of State; 2006. www.state. gov/g/prm/ (Accessed 15 May 2009)
3. Migration Policy Institute. MPI Data Hub: migration facts, stats and maps. Country comparative data. Migration Policy Institute; 2009. www.migratio ninformation.org/datahub/comparative.cfm. (Accessed 15 May 2009)
4. Phares C, Kapella B, Casano A, et al. Imported Plasmodium falciparum malaria disease in newly arrived refugees: United States. Infectious Diseases Society ofAmerica 46th Annual Meeting. Poster presentation; October 2008; Washington, DC.
5. Oeltmann JE, Varma JK, Ortega L, et al. Multidrug-resistant tuberculosis outbreak among US-bound Hmong refugees, Thailand, 2005. Emerg Infect Dis 2008; 14:1715-1721.
6. Barnett EB, Walker PF. Role of immigrants and migrants in emerging Centers for Disease Control and Prevention. Cost of vaccinating refugees overseas versus after arrival in the United States, 2005. MMWR Morb Mortal Wkly Rep 2008; 57:229-232.
7. Centers for Disease Control and Prevention. Division of Global Migration and Quarantine. Revision of 42 CFR Part 34 (Medical Examination of Aliens) Updated Screening for Communicable Disease of Public Health Significance: Interim Final Rule (IFR). www.cdc.gov/ncidod/dq/ifr-main.htm. (Accessed 17 May 2009)
8. U.S. Department of Health and Human Services. Administration for Children and Families. Office of Refugee Resettlement. The Refugee Act. www.acf.hhs.gov/programs/orr/policy/refact1.htm. (Accessed 17 May 2009)
9. Gushulak BD, MacPherson DW. Globalization of infectious diseases: the impact of migration. Clin Infect Dis 2004; 38:1625-1631.
10. Maroushek S, Arguilar EF, Stauffer WM, Abd-Alla MD. Malaria parasitemia in asymptomaticLiberianrefugeechildren.PediatrInfectDisJ2005;24:450-452.
11. Ndao M, Bandyayera E, Kokoskin, et al. Comparison of blood smear, antigen detections, and nested-PCR methods for screening refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada. J Clin Microbiol 2004; 42:2694-2700.
12. Stauffer WM, Newberry AM, Cartwright CP, et al. Evaluation of malaria screening in newly arrived refugees to the United States by microscopy and rapid antigen capture enzyme assay (Binax-NowTM). Pediatr Infect Dis J 2006; 25:948-950.
13. Collinet-Adler S, Stauffer W, Williams DN, et al. Malaria imported into the First documented cost-effectiveness model for presumptive therapy programs for US bound refugees.
14. Bigaillon C, Spiegel A. Ineffectiveness of the Binax NOW Malaria Test for diagnosis of Plasmodium ovale malaria. J Clin Microbiol 2005; 43:1011.
15. Muennig P, Pallin D, Sell RL, Chan MS. The cost effectiveness of strategies for the treatment of intestinal parasites in immigrants. N Engl J Med 1999; 341:377-378. (Pubitemid 29350317)
16. Miller JM, Boyd HA, Ostrowski SR. Malaria, intestinal parasites and schisto-somiasis among Barawan Somali refugees resettling to the United States: a strategy to reduce morbidity and decrease the risk of imported infections. Am J Trop Med Hyg 2000; 62:115-121.
17. Swanson SJ, Lee B, Mamo B, Stauffer W. Changing prevalence of intestinal parasites among newly arrived Southeast Asian and African refugees after empiric predeparture albendazole treatment: Minnesota, 1993-2004. In: Proceedings of the 55th Annual Epidemic Intelligence Service (EIS) Conference; April 2006; Atlanta, GA.
18. Geltman PL, Cochran J, Hedgecock C. Intestinal parasites among African refugees resettled in Massachusetts and the impact of an overseas pre-departure treatment program. Am J Trop Med Hyg 2003; 69:657-662.
19. Posey DL, Blackburn BG, Weinberg M, etal. High prevalence and presumptive treatment of schistosomiasis and strongyloides among African refugees. Clin Infect Dis 2007; 45:1210-1215.
20. Lim S, Katz K, Krajden S, et al. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004; 171:479-484.
21. Newberry AM, Williams DN, Stauffer WM, et al. Strongyloides hyperinfection presenting as acute respiratoryfailure and gram-negative sepsis. Chest 2005; 128:3681-3684.
22. Nash TE, Ohl CA, Thomas E, et al. Treatment of patients with refractory giardiasis. Clin Infect Dis 2001; 33:22-28.
23. Schantz PM. Tapeworms (cestodiasis). Gastroenter Clin N Am 1996; 25: 627-653.
24. Meltzer E, Percik R, Shatzkes J, et al. Eosinophilia among returning travelers: a practical approach. Am J Trop Med Hyg 2008; 78:702-709.
25. Seybolt LM, Christiansen D, Barnett ED. Diagnostic evaluation of newly arrived asymptomatic refugees with eosinophilia. Clin Infect Dis 2006; 42: 363-367.
26. Centers for Disease Control and Prevention. Trends in tuberculosis: United States, 2007. MMWR Morb Mortal Wkly Rep 2008; 57:281-285.
27. Centers for Disease Control and Prevention. Division of Global Migration and Quarantine. Technical Instructions for Civil Surgeons. Centers for Disease Control and Prevention; 2009. http://origin.cdc.gov/ncidod/dq/civil.htm. (Accessed 17 May 2009)
28. Bernardo J. Tuberculosis. In: Walker PF, Barnett ED, editors. Immigrant medicine. Philadelphia: Elsevier, Inc.; 2007. pp. 255-271.
29. Nnoaham KE, Clarke A. Low serum vitamin D levels and tuberculosis: a systemic review and meta-analysis. Int J Epidemiol 2008; 37:113-119.
30. Gibney KB, MacGregor L, Leder K, et al. Vitamin D deficiency is associated with tuberculosis (TB) and latent TB infection among immigrants from sub-Saharan Africa. Clin Infect Dis 2008; 46:443-446.
31. Stauffer WM, Cartwright CP, Olson DA, et al. Superior diagnostic performance of malaria rapid diagnostic tests as compared to blood smears in U.S. Clinical Practice. Clin Infect Dis (in press).